11/13
09:00 am
inmb
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
Low
Report
INmune Bio Inc. Announces Final Enrollment of 208 Patients in Phase 2 Trial in Early Alzheimer's Disease
11/3
08:39 am
inmb
INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023) [Yahoo! Finance]
Low
Report
INmune Bio Third Quarter 2024 Earnings: US$0.60 loss per share (vs US$0.48 loss in 3Q 2023) [Yahoo! Finance]
10/31
04:05 pm
inmb
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
Medium
Report
INmune Bio Inc. Announces Third Quarter 2024 Results and Provides Business Update
10/28
08:00 am
inmb
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
Medium
Report
INmune Bio Inc. to Host Webinar on Cognitive Testing Using EMACC and CDR-SB
10/24
03:08 pm
inmb
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination [Yahoo! Finance]
Low
Report
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination [Yahoo! Finance]
10/24
03:03 pm
inmb
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
Medium
Report
INmune Bio Inc. Announces Publication in Cell Reports Demonstrating XPro™ Promotes Remyelination
10/24
09:30 am
inmb
INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
Medium
Report
INmune Bio Inc. to Report Third Quarter 2024 Financial Results and Provide Corporate Update on October 31, 2024
10/24
08:09 am
inmb
Insider Stock Buying Reaches US$951.2k On INmune Bio [Yahoo! Finance]
Low
Report
Insider Stock Buying Reaches US$951.2k On INmune Bio [Yahoo! Finance]
10/31/2024
04:05 pm
INMB
inmune bio inc. - common stock
MISS
Report
3.2%
inmune bio inc. - common stock
11/14
04:01 pm
inmb
Form 8-K Inmune Bio, Inc. For: Nov 13
Medium
Report
Form 8-K Inmune Bio, Inc. For: Nov 13
11/13
06:08 am
inmb
Form 8-K Inmune Bio, Inc. For: Nov 13
Low
Report
Form 8-K Inmune Bio, Inc. For: Nov 13
11/1
04:24 pm
inmb
Form 8-K Inmune Bio, Inc. For: Oct 31
Low
Report
Form 8-K Inmune Bio, Inc. For: Oct 31
10/31
04:01 pm
inmb
Form 10-Q Inmune Bio, Inc. For: Sep 30
Low
Report
Form 10-Q Inmune Bio, Inc. For: Sep 30
10/28
04:01 pm
inmb
Form 8-K Inmune Bio, Inc. For: Oct 28
Low
Report
Form 8-K Inmune Bio, Inc. For: Oct 28
10/25
04:01 pm
inmb
Form 8-K Inmune Bio, Inc. For: Oct 24
High
Report
Form 8-K Inmune Bio, Inc. For: Oct 24
10/25
10:16 am
inmb
Form SC 13G Inmune Bio, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
Medium
Report
Form SC 13G Inmune Bio, Inc. Filed by: HIGHBRIDGE CAPITAL MANAGEMENT LLC
10/24
04:00 pm
inmb
Form 8-K Inmune Bio, Inc. For: Oct 24
Medium
Report
Form 8-K Inmune Bio, Inc. For: Oct 24
News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings
Order Stats
Sub-Penny
Odd lot
Avg. bid-ask spread
Avg. bid-ask size
Shares at ask/bid
Off exchange
Main News & Impact Reports
3/11
Form 10-K Inmune Bio, Inc. For: Dec 31
26.3%
4/24
Form 424B3 Inmune Bio, Inc.
20.9%
10/21
Form 8-K Inmune Bio, Inc. For: Oct 16
13.8%
10/17
INmune Bio, Inc. Announces Presentation of Data Related to its Lead Compound XPro1595 at the Society for Neuroscience’s Annual Meeting
12.2%
12/17
INmune Bio Announces Final Phase I Clinical Data for its Soluble TNF Inhibitor, INB03, Demonstrates Efficacy and Safety; INB03 is Advancing to Phase II Trials
11.8%
9/4
INmune Bio Inc. to Introduce NeuLiv™ Program for Treatment of NASH at H.C. Wainwright 21st Annual Global Investment Conference
10.9%
8/21
Form 4 Inmune Bio, Inc. For: Aug 20 Filed by: Tesi Raymond Joseph
9.1%
4/20
INmune Bio, Inc. Announces Initiation of Clinical Program Targeting Soluble TNF to Determine if the Company’s TNF Inhibitor (DN-TNF) Platform May Prevent Complications of Cytokine Storm Caused by COVID-19
7.7%
9/4
Form 8-K Inmune Bio, Inc. For: Sep 04
7.7%
8/16
Form 3 Inmune Bio, Inc. For: Aug 06 Filed by: Baracchini Edgardo Jr
7.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:
Register